The Life Sciences Industry Conference 2026 has announced four themes that together offer one of the most grounded and honest examinations of artificial intelligence in pharmaceutical manufacturing that Ireland's life sciences community has seen on a conference agenda. Each theme pairs a 15-minute stage presentation with a 45-minute panel, designed to move beyond headline claims and into the real questions that regulated manufacturers and life sciences leaders are working through right now.

Theme 01, Trust, Governance and Responsible AI, opens the conversation at the level where most organisations are currently stuck: how to innovate with AI while remaining compliant in a highly regulated environment. Governance, regulation, data quality, cybersecurity, validation, and accountability all fall within this theme's scope, framed around the question that is on most leaders' minds: can we trust AI enough to scale it?

Theme 02, Scaling AI from Pilot to Production, addresses what is perhaps the most persistent challenge in pharmaceutical AI adoption. There is no shortage of pilots; the gap between proof of concept and enterprise-wide deployment is where most AI programmes stall. The session will examine the data foundations, integration requirements, change management considerations, and return on investment thinking that determine whether an AI initiative progresses beyond the pilot phase or remains a well-intentioned experiment.

Theme 03, People, Skills and Organisational Change, brings the conversation back to the dimension that technical discussions most often overlook. AI adoption is a people challenge first. Preparing the workforce for new ways of working, building the skills that AI-augmented roles require, and keeping human expertise genuinely central to decision-making are the subjects this theme addresses, framed by the question of what the human side of AI adoption actually looks like in a pharmaceutical manufacturing context.

Theme 04, The AI-Ready Enterprise, closes the conference with a leaders' panel on strategy, investment priorities, and competitive advantage, examining what an AI-ready pharmaceutical manufacturing organisation looks like in five years and how leadership teams should be thinking about the transition now.

Full details and registration are available at pharmaawards.ie/conference, and subscribe to the newsletter to stay informed on speaker announcements and agenda updates.